Lam Research Co. (NASDAQ:LRCX) Shares Sold by LSV Asset Management

LSV Asset Management decreased its holdings in shares of Lam Research Co. (NASDAQ:LRCX) by 33.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,800 shares of the semiconductor company’s stock after selling 1,400 shares during the quarter. LSV Asset Management’s holdings in Lam Research were worth $2,193,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in LRCX. Fisher Asset Management LLC boosted its holdings in Lam Research by 3.0% in the 4th quarter. Fisher Asset Management LLC now owns 2,972,650 shares of the semiconductor company’s stock worth $2,328,358,000 after acquiring an additional 85,855 shares during the period. Morgan Stanley lifted its holdings in Lam Research by 3.2% in the 3rd quarter. Morgan Stanley now owns 1,857,918 shares of the semiconductor company’s stock worth $1,164,490,000 after buying an additional 56,824 shares in the last quarter. Northern Trust Corp boosted its position in Lam Research by 9.7% in the 3rd quarter. Northern Trust Corp now owns 1,523,215 shares of the semiconductor company’s stock valued at $954,705,000 after buying an additional 134,558 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of Lam Research by 12.3% during the fourth quarter. Van ECK Associates Corp now owns 776,885 shares of the semiconductor company’s stock valued at $608,503,000 after acquiring an additional 85,102 shares in the last quarter. Finally, WCM Investment Management LLC increased its position in shares of Lam Research by 0.6% during the fourth quarter. WCM Investment Management LLC now owns 600,594 shares of the semiconductor company’s stock worth $474,271,000 after acquiring an additional 3,717 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Lam Research

In other Lam Research news, CAO Christina Corrreia sold 647 shares of the company’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $628,903.41. Following the transaction, the chief accounting officer now owns 5,541 shares of the company’s stock, valued at $5,386,018.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of Lam Research stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the transaction, the director now directly owns 10,541 shares in the company, valued at approximately $10,246,168.23. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Christina Corrreia sold 647 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total value of $628,903.41. Following the completion of the sale, the chief accounting officer now owns 5,541 shares of the company’s stock, valued at approximately $5,386,018.23. The disclosure for this sale can be found here. Insiders have sold 7,489 shares of company stock valued at $6,978,065 in the last quarter. Insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft assumed coverage on Lam Research in a research note on Thursday, April 11th. They set a “hold” rating and a $1,000.00 price objective for the company. The Goldman Sachs Group upped their price target on shares of Lam Research from $700.00 to $912.00 and gave the company a “buy” rating in a report on Thursday, January 25th. Raymond James raised their price objective on shares of Lam Research from $850.00 to $950.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Citigroup upped their target price on shares of Lam Research from $975.00 to $1,025.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Finally, UBS Group lifted their price target on Lam Research from $1,130.00 to $1,150.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Seven analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and an average target price of $950.85.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $907.54 on Friday. The company has a current ratio of 2.82, a quick ratio of 1.84 and a debt-to-equity ratio of 0.56. The firm’s 50 day moving average is $940.52 and its two-hundred day moving average is $825.36. The firm has a market capitalization of $118.65 billion, a P/E ratio of 33.38, a PEG ratio of 2.82 and a beta of 1.51. Lam Research Co. has a 52 week low of $520.05 and a 52 week high of $1,007.39.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 EPS for the quarter, topping the consensus estimate of $7.26 by $0.53. The firm had revenue of $3.79 billion for the quarter, compared to analysts’ expectations of $3.72 billion. Lam Research had a return on equity of 45.96% and a net margin of 25.35%. The firm’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.99 earnings per share. Analysts anticipate that Lam Research Co. will post 29.62 earnings per share for the current year.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.